Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-26-030107

President & Immunovant CEO sold 200,000 shares at $34.95 ($6,990,000)

  • President & Immunovant CEO acquired 200,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2026-07-27 Option exercise 10b5-1 +200,000 $3.85 $770,000 1,813,063 D
Venker Eric President & Immunovant CEO 2026-07-27 Sale 10b5-1 −200,000 $34.95 $6,990,000 1,613,063 D
Derivatives
Venker Eric President & Immunovant CEO 2026-07-27 Option exercise · Stock Option (Right to Buy) 10b5-1 −200,000 4,044,834 D
Open-market sales · 200,000 sh · avg $34.95 · $6,990,000
Loading xslF345X06/form4.xml…